Skip to main content
Equibles
EYPT logo

EYPT · EyePoint, Inc. · Metrics

Track EYPT — free

Use EYPT with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research EYPT.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$0.40 0.00 (-1.23%) At close · Nov 4 Play latest call Q1 2026 earnings call transcript
Russell 2000 member Rebalance outlook locked
Market Cap
$34.05M
Shares
86.21M
Volume · Nov 4 3.07M Avg daily vol (3M) 9.03M

EYPT metrics

75 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$0.40
Market cap
$34.05M

Price action

20 metrics
Price change (1W)
+10.1%
Price change (30D)
-87.3%
Price change (3M)
-96.6%
Price change (6M)
-97.1%
Price change (YTD)
-97.8%
Price change (1Y)
-96.8%
Trailing year
Price change (5Y)
-96.8%
52-week high
$18.85
52-week low
$0.35
Change from 52-week high
-97.9%
Change from 52-week low
+14.8%
Annualized volatility
131.6%
Annualized volatility (3M)
231.5%
Beta
1.2
RSI (14D)
17.4
Price vs SMA 50
-86.8%
Price vs SMA 200
-96.3%
Avg volume (3M)
9.03M
Relative volume
0.4
Average dollar volume
$21.51M

Company

3 metrics
Sector
Healthcare
Industry
Biotechnology
Shares outstanding
86.21M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
-52.4×
EV / EBITDA
—
EV / EBIT
—
P / sales
12.4×
reciprocal yield 8.1%
P / book
0.2
reciprocal yield 482.7%
FCF yield
-786.9%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-889.4%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
45.4×
reciprocal yield 2.2%
EV / revenue historical average (5Y)
28.1×
reciprocal yield 3.6%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-10-19

Profitability

9 metrics
Gross margin
—
Operating margin
-11,369.3%
Trailing 12 months
Net margin
-10,998.7%
Gross profit (TTM)
—
Operating profit (TTM)
−$316.98M
Net income (TTM)
−$306.64M
Trailing 12 months
Diluted EPS (TTM)
$-3.75
FCF margin
-9,730.2%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$3.70

Growth

11 metrics
Revenue growth YoY
-90.5%
Year over year
Net income growth YoY
—
Revenue (TTM)
$2.79M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+23.8%
Year over year · more shares
Revenue CAGR (3Y)
-8.8%
Revenue CAGR (5Y)
-1.8%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-184.3%
Return on assets
-134.4%
Debt / equity
0.0
Current ratio
4.5
EBITDA (TTM)
−$314.38M
Free cash flow (TTM)
−$271.28M
Quick ratio
4.5
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$180.47M
Latest balance sheet
Cash & equivalents
$110.46M
Total assets
$228.19M
Total debt
$0

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$267.30M
Capital expenditures (TTM)
$3.98M
R&D (TTM)
$262.73M
SG&A (TTM)
—
Stock compensation (TTM)
$35.21M
R&D / revenue
9,423.6%
Stock compensation / revenue
1,263.0%

Ownership (13F)

9 metrics
13F filers
194
13F filer change QoQ
+1
Institutional ownership
112.8%
Conviction holders (share of 13F filers)
3.7%
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
+5.2%
Holder tenure
11.5
Price vs estimated holder cost
+14.5%

Ownership (registered funds)

1 metrics
Index-fund ownership
13.5%

Short interest

3 metrics
Short interest
24.7%
Latest settlement · 8.1 days to cover
Days to cover
8.1d
Short-squeeze score
68 / 100

Insider activity

2 metrics
Net insider buying (90D)
$52,258
Insider-sentiment score
77 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 1314102 CUSIP 30233G209 13F (30d) 35 filings 34 filers Visit website Investor relations